Could stem cells offer new hope for autoimmune lung damage?
NCT ID NCT06574581
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a stem cell treatment for people with autoimmune diseases (like lupus or scleroderma) that cause lung scarring and breathing problems. Sixteen adults will receive infusions of donor fat-derived stem cells to see if it is safe and can improve lung function. The goal is to control the disease and reduce the need for stronger medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONNECTIVE TISSUE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China Medical University Hospital
RECRUITINGTaichung, 404327, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Virtual Nurse-Social worker team aims to ease symptoms for veterans with heart failure and COPD
- AI outruns radiologists in detecting early lung scarring
- Smart home tech could help lung patients breathe easier at home
- Beetroot juice may boost exercise in lung scarring disease
- Scientists hunt for clues in the blood to predict lung fibrosis outcomes
- Lung disease mystery: 1500 patients to be tracked for clues